• 제목/요약/키워드: Parathyroid hormone-related protein

검색결과 14건 처리시간 0.019초

폐암환자에서 인체 부갑상선 호르몬 관련 단백에 대한 연구 (Human Parathyroid Hormone-Related Peptide Measurement in the Lung Cancer Patients)

  • 장준;김세규;임승길;이홍렬;김성규;이원영
    • Tuberculosis and Respiratory Diseases
    • /
    • 제42권6호
    • /
    • pp.855-861
    • /
    • 1995
  • 연구배경: 악성 종양 환자에서 PTHrp가 고칼슘혈증을 유발시킬 수 있음이 밝혀졌으며, 악성 종양 특히 편평상피세포 폐암에서 골 전이 없이 고칼슘혈증이 종종 관찰되므로 PTHrp가 암의 진행정도 및 예후와 관련이 있을 가능성이 있다. 정상 칼슘혈증인 폐암환자에서도 혈중 PTHrp를 측정하는 예민한 검사법을 이용하면 편평상피 폐암의 조기진단, 치료반응의 추적, 재발의 발견등에 도움을 받을 가능성이 있다. 방법: 조직학적으로 진단된 폐암 환자군 및 대조군의 혈중 PTHrp를 방사면역학 검사로 측정하여 폐암환자에서 각 세포형, 병기, 골 전이 유무에 따른 PTHrp의 혈중치와 혈청 칼슘 및 인, 24시간 요중 칼슘 및 인의 배설량과의 관계를 조사하였다. 결과: 혈청 PTHrp(평균$\pm$S.E.)는 대조군(n=22) $158{\pm}38.2pg/ml$, 전체 폐암군(n=63) $312{\pm}68.9pg/ml$으로 폐암군에서 높은 경향이지만 유의한 차이는 없었다. 각 세포형에 따라서는 편평상피세포암군(n=34) $356{\pm}103.9pg/ml$, 선암군(n=15) $281{\pm}148.7pg/ml$, 소세포암군(n=9) $316{\pm}140.8pg/ml$, 대세포암(n=1) 65.0pg/ml, 미분화 미분류 세포암군(n=4) $114{\pm}77.9pg/ml$로 편평상피세포암군에서 높은 경향이나 각 군 및 대조군 간에 유의한 차이가 없었다. 편평상피암의 병기에 따른 혈청 PTHrp(평균$\pm$S.E.)는 제 I병기(n=1) 143pg/ml, 제 II병기(n=3) $570{\pm}472.3pg/ml$, 제 IIIa 병기(n=9) $166{\pm}22.4pg/ml$, 제 IIIb 병기(n=12) $282{\pm}113.3pg/ml$, 제 IV 병기(n=9) $668{\pm}367.9pg/ml$로 제 II 병기와 제 IV 병기에서 대조군에 비해 유의하게 높았다(p<0.05). 골 전이가 있는 편평상피암(n=8)의 경우 혈청 PTHrp $1526{\pm}811.2\;pg/ml$로 대조군에 비해 유의하게 높았으나(p<0.0005), 골 전이가 없는 군은 대조군과 차이가 없었고, 혈청 및 24 시간 뇨중 calcium, phosphorus의 차이도 관찰되지 않았다. 고칼슘혈증은 편평상피암 1예에서 관찰되었으며, 이 예에서 PTHrp는 244pg/ml로 높지 않았다. 대조군, 폐암군, 폐암의 세포형 및 폐암의 병기에 따른 군간에 혈청 calcium, phosphorus, 24시간 뇨중 calcium, phosphorus에 유의한 차이가 없었다. 결론: 혈중 PTH게는 대조군에서도 상당량 검출이 되며, 정상 칼슘혈증인 폐암환자에서 다수 검출되고, PTHrp가 높아도 고칼슘혈증이 동반되지 않는 등 PTHrp로 종양의 체액성 고칼슘혈증 기전을 모두 설명할 수는 없으며, 폐암 조기발견의 표지자, 병기 및 예후 예측 인자로는 PTHrp 1-34 측정이 부적합하다고 판단 되지만 골 전이가 있는 진행된 예에서 증가하는 경향이므로 병기와 예후 예측인자, 치료 반응 및 재발 등에서의 응용 가능성에 대하여 적극적으로 검토할 가치가 있다. 앞으로 고캄슘혈증 환자에서 보다 많은 예를 시행하고 특이성이 높은 검사법을 개발하는 등의 추후 연구도 필요하다.

  • PDF

폐경 후 골감소증 여성에 대한 12주간의 영양교육과 운동 중재 전.후 식품 및 영양소 섭취량 변화와 골밀도 지표 변화와의 관계 (The Association between Changes in Food and Nutrient Intakes and Changes in Bone Metabolic Indicators in Postmenopausal Women with Osteopenia after a 12-week Intervention of Nutrition Education and Aerobic Exercise)

  • 김서진;강서정;박윤정;황지윤
    • 대한지역사회영양학회지
    • /
    • 제18권3호
    • /
    • pp.213-222
    • /
    • 2013
  • Few studies investigated the effects of nutrition education and exercises in women with osteopenia. This study examined the relationship between changes in dietary intakes and changes in indicators related to bone health in postmenopausal women with osteopenia (-2.5 ${\leq}$ T-score ${\leq}$ 1) after a 12-week intervention. Thirty-one postmenopausal women aged > 50 years residing in Seoul were recruited and participated in nutritional education regarding bone health and general nutrition practices and aerobic exercises (three times a week; 60 min per session). Twenty-five subjects completed the study and were eligible for the analysis. Bone mineral density (BMD) at femoral neck was measured by dual energy x-ray absorptiometry. Serum calcium, osteocalcin, and intact parathyroid hormone (PTH) were also measured. Dietary intake was estimated by using a one-day 24 recall by a clinical dietitian. After 12 weeks, meat consumption increased (P = 0.028) but vegetable intake decreased (P = 0.005). Intakes of animal protein (P = 0.024), vitamin B1 (P = 0.012) and vitamin $B_2$ (P = 0.047) increased, and sodium intake decreased (P = 0.033). Intact PTH (P = 0.002) decreased and osteocalcin (P = 0.000) increased, however, BMD decreased (P = 0.000). Changes in mushroom consumption were positively correlated with femoral neck BMD (r = 0.673, P = 0.003). Changes in animal iron intake were negatively correlated with intact PTH (r = -0.488, P = 0.013) but were positively correlated with osteocalcin (r = 0.541, P = 0.005). These results suggested that the association between animal iron intake and biochemical markers of bone turnover may play an important role in bone metabolism. Further studies are needed to shed light on complicated mechanisms of diet, hormonal levels of bone metabolism, and bone density.

Impact of Chemotherapy on Hypercalcemia in Breast and Lung Cancer Patients

  • Hassan, Bassam Abdul Rasool;Yusoff, Zuraidah Binti Mohd;Hassali, Mohamed Azmi;Othman, Saad Bin;Weiderpass, Elisabete
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권9호
    • /
    • pp.4373-4378
    • /
    • 2012
  • Introduction: Hypercalcemia is mainly caused by bone resorption due to either secretion of cytokines including parathyroid hormone-related protein (PTHrP) or bone metastases. However, hypercalcemia may occur in patients with or without bone metastases. The present study aimed to describe the effect of chemotherapy treatment, regimens and doses on calcium levels among breast and lung cancer patients with hypercalcemia. Methods: We carried a review of medical records of breast and lung cancer patients hospitalized in years 2003 and 2009 at Penang General Hospital, a public tertiary care center in Penang Island, north of Malaysia. Patients with hypercalcemia (defined as a calcium level above 10.5 mg/dl) at the time of cancer diagnosis or during cancer treatment had their medical history abstracted, including presence of metastasis, chemotherapy types and doses, calcium levels throughout cancer treatment, and other co-morbidity. The mean calcium levels at first hospitalization before chemotherapy were compared with calcium levels at the end of or at the latest chemotherapy treatment. Statistical analysis was conducted using the Chi-square test for categorical data, logistic regression test for categorical variables, and Spearman correlation test, linear regression and the paired sample t tests for continuous data. Results: Of a total 1,023 of breast cancer and 814 lung cancer patients identified, 292 had hypercalcemia at first hospitalization or during cancer treatment (174 breast and 118 lung cancer patients). About a quarter of these patients had advanced stage cancers: 26.4% had mild hypercalcemia (10.5-11.9 mg/dl), 55.5% had moderate (12-12.9 mg/dl), and 18.2% severe hypercalcemia (13-13.9; 14-16 mg/dl). Chemotherapy lowered calcium levels significantly both in breast and lung cancer patients with hypercalcemia; in particular with chemotherapy type 5-flurouracil+epirubicin+cyclophosphamide (FEC) for breast cancer, and gemcitabine+cisplatin in lung cancer. Conclusion: Chemotherapy decreases calcium levels in breast and lung cancer cases with hypercalcemia at cancer diagnosis, probably by reducing PTHrP levels.

폐경 후 여성의 골격상태에 영향을 미치는 요인분석 (Some Factors Affecting Bone Mineral Status of Postmenopausal Women)

  • 오세인;이행신;이미숙;김초일;권인순;박상철
    • 대한지역사회영양학회지
    • /
    • 제7권1호
    • /
    • pp.121-129
    • /
    • 2002
  • Osteoporosis, the typical metabolic bone disease of the elderly, is characterized by a reduction in bone mineral density (BMD) and increased fracture risk. Genetic and environmental factors are known to play a key role in bone metabolism, and diet is also considered to be one of the important factors. The purpose of the present study was to investigate the relationship among the factors affecting BMD, including stature, body weight, age, time period since onset of menopause, and biochemical markers of bone turnover in postmenopausal women. Seventy-eight postmenopausal women who visited health promotion center for health examinations volunteered to participate in this study and they were divided into two groups according to the time period since onset of menopause : women with a time period since onset of menopause of less than 5 years (Group 1) and women with a time period since onset of menopause of 5 years or more (Group 2). The demographic characteristics and dietary intake were surveyed using a questionnaire. BMDs of the lumbar spine and femoral neck of subjects were measured by dual energy X-ray absorptiometry. Serum levels of 25-hydroxy-vitamin D and parathyroid hormone (PTH), known to be indicators of bone related hormone status, were anlyzed. Serum samples were measured for calcium, phosphorus, alkaline phosphatase, and osteocalcin as bone formation indicators, and urine was analysed for deoxypyridinoline, creatinine, calcium, and sodium as bone resorption indicators. The results are as follow : The mean BMDs of the lumbar spin and femoral neck were $1.02 \pm 0.02 g/cm^2 and 0.81 \pm 0.02 g/cm^2 respectively, and the BMD level of Group 2 was significantly lower than tat of Group 1 (p<0.01, p<0.05, respectively). The mean daily intake of energy was 1838 $\pm$ 55 kcal. When nutrient intake was compared with the recommended dietary allowances (RDA) of the subjects, only calcium, vitamin A and riboflavin intake showed means lower than the RDA. The nutrient intake did not show any significant differences between Group 1 and 2 Serum and urine levels of biochemical markers of bone turnover did not show any significant differences between Group 1 and 2, and all were within the normal range. However, the PTH and deoxypyridinoline levels showed a tendency to be higher, and the osteocalcin level to be lower in Group 2 than in Group 1. Although age and years after menopause (YAM) showed negative correlations with lumbar spine bone mineral density (LBMD) (r= -0.38, p<0.001, and r= -0.26, p< 0.05, respectively), no correlation was found with femoral neck bone mineral density (NBMD). While height, body weight and body mass index (BMI) showed a positive correlation with LBMD (r= 0.32, p<0.001, r= 0.38, p<0.001, r= 0.22, p= 0.05, respectively), only body weight and BMI showed a positive correlation with NBMD (r= 0.30, p<0.01, and r= 0.27, p<0.05, respectivley). There was no significant corealtion between BMDs and the nutrient intake of subjects, except in the case of carbohydrates (r= 0.22, p<0.05). Also, serum and urine levels of bone turnover markers showed no significant correlation with nutrient intake. On the other hand, serum osteocalcin had a positive correlation with vitamin C intake (r= 0.22, p= 0.05), and urine deoxypyridinolin showed a negative correlation with niacin intake (r= -0.22, p= 0.05). Urinary na was negatively correlated with protein intake(r= -0.23, p= 0.05). The results suggested that it is difficult to prevent the decrease in bone mass among postmenopausal women eating the usual Korean diet. However, the BMDs of the lumbar spine and femoral neck were positively related to body weight ad BMI in postmenopausal women. Therefore, this study confirmed that one of the most effective ways to minimize bone loss in postmenopausal women would be to maintain an adequate body weight with balanced nutrient intake and activity in the pre-and postmenopausal periods.